Clinical trial Recruiting at 1 site Phase 3 Interventional

Biodegradable amiodarone patches placed on the heart to prevent atrial fibrillation after open-heart surgery

Official title: BiodEgradable Soaked Amiodarone paTch Use for the Prevention of Atrial Fibrillation After Cardiac Surgery

Run by Jilin Heart Hospital · NCT06722196 · Data updated 2026-11-12

This trial will try placing biodegradable patches soaked with amiodarone on the outside of the atria during open-heart surgery to see if it reduces new atrial fibrillation after elective cardiac operations.

More Atrial Fibrillation (AF) trials

Quick facts

PhasePhase 3
Study typeInterventional
SexAll
Enrollment500 (estimated)
SponsorJilin Heart Hospital
Academic / other
Locations1 site (Changchun, Jinlin)
StatusRecruiting
StartedFebruary 15, 2025
Main results expectedJanuary 15, 2027
Study endsDecember 15, 2027
Registry record updatedDecember 9, 2025
Trial IDNCT06722196 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults scheduled for elective full-sternotomy cardiac surgery (coronary, valve, or ascending aorta procedures) who do not have a prior history of atrial or ventricular arrhythmia and who do not have pacemakers/ICDs, thyroid dysfunction, HOCM, or emergency/reoperative indications.

Probably not a fit

Patients with prior atrial or ventricular arrhythmias, those undergoing reoperation or emergency surgery, and those with pacemakers/ICDs, thyroid dysfunction, or HOCM are unlikely to qualify and are not expected to benefit from this intervention.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This randomized, double-blind, controlled Phase 3 trial compares two oxidized regenerated cellulose patches soaked with amiodarone versus saline applied over the anterior left atrium and lateral right atrium at the end of elective full-sternotomy cardiac surgery. Eligible procedures include coronary artery bypass, aortic, mitral, tricuspid, and ascending aorta operations performed on- or off-pump, while patients with prior atrial or ventricular arrhythmias, reoperations, emergency indications, pacemakers/ICDs, thyroid dysfunction, or HOCM are excluded. The primary outcome is the incidence of postoperative atrial fibrillation (POAF), with blinded outcome assessment and standard postoperative monitoring. The intervention aims to deliver local antiarrhythmic therapy to the atrial surface with limited systemic exposure compared with systemic drug dosing.

Why it matters

Potential benefit: If successful, this approach could lower rates of postoperative atrial fibrillation, reducing complications and potentially shortening hospital stays.

How similar studies have gone: Smaller clinical and experimental studies of topical or epicardial amiodarone have shown mixed but often encouraging reductions in POAF, while large-scale phase 3 evidence for soaked biodegradable patches remains limited.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* All patients who are candidates for elective cardiac surgery trough complete sternotomy with indications of coronary artery disease (both off-pump and on-pump), aortic valve disease, mitral valve disease, tricuspid valve disease, and ascending aorta disease, whether as an isolated pathology or in combination

Exclusion Criteria:

* patients with a clinical history of atrial or ventricular arrhythmia of any nature and duration, patients undergoing reoperation, patients with emergency surgical indications due to acute myocardial infarction or cardiogenic shock, patients with thyroid disfunction, patients with HOCM and those with pacemakers or ICDs

Where it's running

  • Jilin Heart Hospital
    Changchun, Jinlin, China
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.